Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Lymphoid 1

Conditions

Prostatic Neoplasms 5Ovarian Neoplasms 4Breast Neoplasms 4Pancreatic Neoplasms 3Colorectal Neoplasms, Hereditary Nonpolyposis 3Triple Negative Breast Neoplasms 2Neoplastic Syndromes, Hereditary 2Hereditary Breast and Ovarian Cancer Syndrome 2Endometrial Neoplasms 2Colorectal Neoplasms 2Sarcoma 1Rectal Neoplasms 1Multiple Myeloma 1Melanoma 1Lymphoproliferative Disorders 1Kidney Neoplasms 1Hematologic Neoplasms 1Fanconi Anemia, Complementation Group D1 1Cytopenia 1Congenital Bone Marrow Failure Syndromes 1Colonic Neoplasms 1Carcinoma, Ovarian Epithelial 1Carcinoma, Intraductal, Noninfiltrating 1Cancer Risk Syndrome 1Breast Neoplasms, Male 1Bone Marrow Failure Disorders 1Advanced Malignant Neoplasm 1

Interventions

plerixafor 1Specimen Handling 1Radiotherapy 1Oxycodone 1Ondansetron 1Music Therapy 1Morphine 1Methadone 1Granulocyte Colony-Stimulating Factor 1Genetic Testing 1Genetic Counseling 1Follow-Up Studies 1Fluorescent Antibody Technique 1Chromatin Immunoprecipitation Sequencing 1Aprepitant 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Lymphoproliferative Disorders × Genetic Counseling × Clear all
NCT06630104 2026-01-08

Understanding the Mechanisms of Clonal and Non-clonal Cytopenia Following CAR-T Therapy for Multiple Myeloma or CD19+ Lymphoproliferative Disorder (LPD)

Mayo Clinic

Phase NA Recruiting
82 enrolled
LymphoidPlasma cell

Lymphoproliferative Disorders, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡